GlassScriptPhysician profile
Rekha Gohel
NPI 1679653992
$3,029.35
in general payments reported to CMS, 2019-2025
39 companies · $482 in 2025
The $482 reported for 2025 was more than what 78% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $263 · 2021: $186 · 2022: $114 · 2023: $771 · 2024: $725 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,978.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $329.50 | 2019-2025 | Farxiga, Airsupra, Breztri |
| E.R. Squibb & Sons, L.L.C. | $276.59 | 2019-2020 | |
| Novo Nordisk INC | $196.74 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $155.80 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $153.87 | 2023-2025 | Gemtesa |
| Lilly USA, LLC | $143.03 | 2019-2025 | Amyvid, Jardiance, Mounjaro |
| Amgen INC. | $136.70 | 2023-2025 | Repatha, Otezla, Krystexxa |
| Silk Road Medical, INC. | $122.04 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Becton, Dickinson and Company | $120.81 | 2024 | Phasix Mesh |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.23 | 2020-2024 | Jardiance |
| Eisai INC. | $87.39 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $86.53 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $83.64 | 2019-2023 | Belsomra, Januvia |
| Lundbeck LLC | $75.42 | 2023-2025 | Rexulti |
| Acadia Pharmaceuticals INC | $73.64 | 2023 | Nuplazid |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $73.35 | 2023-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $72.59 | 2023-2024 | Arexvy, Trelegy Ellipta |
| Amarin Pharma, INC. | $69.06 | 2019-2023 | |
| Exact Sciences Corporation | $69.06 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $67.48 | 2019-2022 | |
| Life Molecular Imaging LTD | $64.70 | 2024-2025 | Neuraceq |
| Corium, LLC | $58.68 | 2023 | Adlarity, Adlarity |
| Pfizer INC. | $54.10 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $42.24 | 2023-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $39.90 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $38.80 | 2019 | |
| Mylan Specialty L.P. | $34.73 | 2022-2024 | Yupelri |
| Vivus LLC | $26.92 | 2019-2020 | |
| Allergan, INC. | $26.58 | 2019 | |
| Radius Health, INC. | $24.49 | 2019-2020 | |
| Boston Scientific Corporation | $22.11 | 2024 | |
| Xeris Pharmaceuticals, INC. | $16.08 | 2024 | Gvoke Hypopen |
| Teleflex LLC | $15.96 | 2024 | Urolift |
| Ferring Pharmaceuticals INC. | $15.27 | 2023 | Rebyota |
| Bausch Health US, LLC | $15.00 | 2019 | |
| Astellas Pharma US INC | $13.82 | 2020 | |
| Biogen, INC. | $13.10 | 2021 | |
| Daiichi Sankyo INC. | $12.62 | 2019 | |
| Sanofi Pasteur INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rekha Gohel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.